 |
Human Hemin |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of ischemia reperfusion injury in patients undergoing solid organ transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2013-08-06 00:00:00 |
| Sponsor | Borders Technology Management Ltd;2 Broomlee Mains Court, Peeblesshire, EH467JG;Scotland |
